MDAI spectral-ai.com: Forward P/S Multiple

Spectral AI, Inc. (MDAI) is advancing predictive burn diagnostics through partnerships with hospitals and the US defense sector. The expected price-to-sales ratio reflects a valuation trend where the indicator reaches 3.10. However, potential algorithm failures and slow regulatory approvals create risks. Meanwhile, the focus on domestic civilian medicine minimizes geopolitical threats and export restrictions.

spectral-ai.com - MDAI Market Cap to Expected Sales Ratio (period 02/21/2024 - 11/13/2026)

Metric breakdowns and analytics for spectral-ai.com (MDAI)

- current price and projected stock value:

Stock Price Spectral AI, Inc.|MDAI - Average Forecast Price

- company stock capitalization data:

Market Capitalization Spectral AI, Inc.|MDAI - Business Value

- issuer book value statistics:

Book Value per Share Spectral AI|MDAI - Book Valuation of Business|Market Capitalization to Book Value Ratio spectral-ai.com|MDAI - Cumulative Company Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

MDAI - Annual Net Income|Future Profit Spectral AI, Inc.|MDAI - P/E Multiple|Forward P/E Multiple Spectral AI, Inc.|MDAI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Spectral AI, Inc.|MDAI - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Spectral AI|MDAI - Net earnings per share for the last 12 months|Quarterly EPS earnings growth spectral-ai.com|MDAI - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Spectral AI, Inc.

- sales volume and revenue indicators:

MDAI - Company Sales Volume|Company Future Sales Volume Spectral AI|MDAI - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio Spectral AI, Inc.

Summary company analytics:Spectral AI, Inc. (MDAI)

To ensure high-quality stock selection, an investor must correlate market capitalization with expected revenue to avoid uncertainty between reporting periods. This calculation determines the value of each unit of future sales, which, for the scalable AI solutions of Spectral AI, Inc. (MDAI) with low implementation costs, serves as an indicator of expansion rates, reflecting growth potential through the projected P/S ratio.

Key competitors

Forward P/S Multiple ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Market Cap to Future Revenue Ratio|GE Healthcare Corp - Forward P/S Multiple|MTD (Mettler Toledo Inc) - Market Cap to Projected Revenue|WAT: Forward P/S Multiple|TECH - Market Cap to Expected Sales Ratio|BRKR (Bruker) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Azenta Inc (AZTA)|Forward P/S Multiple VREX|Forward P/S Multiple Semler (SMLR)|Price-to-Projected Revenue Ratio Butterfly Network, Inc. BFLY|mesalabs.com - Price-to-Projected Revenue Ratio|QSI: Forward Price-to-Revenue Multiple|Forward Price to Sales NNOX (Nano-X Imaging)|QTRX: Forward P/S Multiple|Market Cap to Future Revenue Ratio 908 Devices Corporation (MASS)|Price-to-Projected Revenue Ratio CapsoVision, Inc.|MXCT - Projected Price to Revenue|Forward Price-to-Revenue Multiple RPID (Rapid Micro Biosystems)|Forward P/S Multiple Seer Inc (SEER)|Forward P/S Multiple HYPR (Hyperfine Corp)|Market Cap to Expected Sales Ratio FONAR Corporation Inc (FONR)|DXR - Price-to-Projected Revenue Ratio|Future Price to Revenue VIVS|Aclarion, Inc. (ACON) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Talis Biomedical Corp TLIS|Price-to-Projected Revenue Ratio T2 Biosystems, Inc. (TTOO)